Mission Statement, Vision, & Core Values of AbbVie Inc. (ABBV)

Ever wondered what drives a global biopharmaceutical giant like AbbVie? With $56.334 billion in net revenues in 2024, how does AbbVie stay focused and aligned?

The answer lies in its clearly defined mission, vision, and core values. But what exactly are these guiding principles, and how do they influence AbbVie's strategic decisions and daily operations? Keep reading to find out!

AbbVie Inc. (ABBV) An Overview of

AbbVie Inc. (ABBV) is a global biopharmaceutical company founded in 2013 as a spin-off from Abbott Laboratories. Headquartered in North Chicago, Illinois, AbbVie discovers, develops, manufactures, and sells pharmaceutical products. The company focuses on treating conditions such as chronic autoimmune diseases, oncology, neuroscience, and virology. Key products include Humira, used to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; Imbruvica, a cancer drug; and Skyrizi and Rinvoq, used for immunological diseases.

In 2024, AbbVie reported strong financial results, driven primarily by its immunology and oncology portfolios. While specific, comprehensive sales figures for 2025 are not yet available, the trends and data from 2024 provide a clear picture of AbbVie's financial trajectory and market position.

AbbVie's financial performance in the latest reporting period demonstrates its robust market presence and growth strategies. In 2024, AbbVie reported a significant revenue increase, driven predominantly by key products and strategic market expansions. Here are some key highlights:

• Total Revenue: AbbVie's total revenue for 2024 reached approximately $54.3 billion, marking a substantial increase from the previous year.
• Humira Sales: Despite facing biosimilar competition, Humira remained a major revenue contributor, generating approximately $14.4 billion in global sales.
• Skyrizi and Rinvoq: These immunology drugs showed impressive growth, with combined sales reaching around $16.5 billion, demonstrating AbbVie's successful diversification in the immunology sector.
• Imbruvica and Venclexta: AbbVie's oncology portfolio also performed strongly, with Imbruvica and Venclexta contributing significantly to the company's revenue.
• International Expansion: AbbVie has strategically expanded its presence in key international markets, driving growth and reducing reliance on the U.S. market.

AbbVie has established itself as a leader in the biopharmaceutical industry through strategic innovation, strong product portfolios, and global market expansion. To gain a deeper understanding of AbbVie's financial health and strategic positioning, explore Breaking Down AbbVie Inc. (ABBV) Financial Health: Key Insights for Investors.

AbbVie Inc. (ABBV) Mission Statement

AbbVie's mission statement is 'to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.' This statement reflects AbbVie's dedication to improving patient health through cutting-edge research and development.

The mission statement encompasses several core components:

• Discovery: Emphasizes AbbVie's commitment to finding new treatments.
• Delivery: Highlights the importance of making these treatments accessible to patients.
• Innovation: Focuses on developing novel medicines.
• Impact: Aims to solve serious health issues and address future medical challenges.

Each of these components plays a vital role in guiding AbbVie's strategic objectives and operational activities.

Discovering Innovative Medicines

AbbVie's commitment to discovering new medicines is evident in its significant investment in research and development. In 2024, AbbVie invested $7.4 billion in R&D, demonstrating its focus on innovation. This investment supports a broad pipeline of potential new therapies across various therapeutic areas, including immunology, oncology, neuroscience, and eye care.

Examples of AbbVie's discovery efforts include:

• Developing new treatments for autoimmune diseases like rheumatoid arthritis and Crohn's disease.
• Researching novel cancer therapies, including targeted therapies and immunotherapies.
• Advancing treatments for neurological disorders such as Alzheimer's disease and Parkinson's disease.

These efforts reflect AbbVie's dedication to pushing the boundaries of medical science to address unmet patient needs.

Delivering Innovative Medicines

Beyond discovery, AbbVie is committed to ensuring that its medicines reach the patients who need them. This involves:

• Navigating complex regulatory pathways to secure approvals for new medicines.
• Establishing efficient manufacturing and supply chain operations to ensure product availability.
• Working with healthcare providers and payers to facilitate patient access to AbbVie's therapies.

In 2024, AbbVie's net revenues were $54.79 billion, reflecting the successful delivery of its products to patients worldwide. A significant portion of these revenues is reinvested into R&D to further drive innovation.

Solving Serious Health Issues

AbbVie focuses on developing treatments for serious health issues that have a significant impact on patients' lives. This includes:

• Chronic diseases that require long-term management.
• Life-threatening conditions that demand innovative therapies.
• Debilitating disorders that impair patients' quality of life.

AbbVie's portfolio includes several blockbuster drugs that address these needs. For example, Humira, used to treat autoimmune diseases, generated substantial revenue before facing biosimilar competition. Newer drugs like Skyrizi and Rinvoq are now key growth drivers, with combined sales of $11.3 billion in 2024, showcasing AbbVie's ability to develop and deliver impactful treatments.

Addressing the Medical Challenges of Tomorrow

AbbVie is proactive in anticipating future medical needs and investing in research to address these challenges. This includes:

• Exploring new technologies such as gene therapy and precision medicine.
• Developing treatments for emerging infectious diseases.
• Addressing the growing burden of age-related diseases.

AbbVie's pipeline includes numerous investigational therapies in early and late-stage development, reflecting its commitment to addressing future medical challenges. The company's long-term vision is to transform the treatment landscape and improve patient outcomes for years to come.

For more insights into AbbVie's history, mission, and operations, you can explore this resource: AbbVie Inc. (ABBV): History, Ownership, Mission, How It Works & Makes Money.

AbbVie Inc. (ABBV) Vision Statement of

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, and women's health, as well as products and services across its Allergan Aesthetics portfolio.

In 2024, AbbVie reported net revenues of $54.795 billion. The company's research and development investment was significant, with $6.829 billion dedicated to advancing its pipeline. AbbVie's financial performance reflects its commitment to innovation and growth in the pharmaceutical industry.

Solving Serious Health Issues

AbbVie focuses on developing solutions for significant health challenges. This commitment is reflected in their strategic allocation of resources towards research and development. AbbVie invests heavily in R&D to discover and develop new therapies. In 2024, AbbVie's R&D expenses totaled $6.829 billion, demonstrating a strong emphasis on innovation.

• Immunology: Developing treatments for chronic autoimmune diseases.
• Oncology: Creating targeted therapies and immunotherapies for various cancers.
• Neuroscience: Addressing neurological disorders with innovative pharmaceutical solutions.
• Eye Care: Providing treatments for various eye conditions.
• Virology: Developing antiviral therapies to combat viral infections.
• Women's Health: Offering a range of products and therapies focused on women's health needs.
• Allergan Aesthetics: Providing products and services in aesthetics.

Addressing Medical Challenges of Tomorrow

AbbVie's vision extends beyond current healthcare needs, focusing on future medical challenges. This forward-looking approach is evident in their strategic investments and research priorities. AbbVie actively engages in clinical trials to assess the safety and efficacy of new treatments. As of 2024, AbbVie has numerous ongoing clinical programs across its therapeutic areas. AbbVie reported a strong financial position, which supports its long-term vision. In 2024, AbbVie's net revenues were $54.795 billion, providing substantial resources for future investments.

• Investing in cutting-edge research and development.
• Collaborating with other companies and research institutions.
• Expanding into new therapeutic areas.

Having a Remarkable Impact on People's Lives

AbbVie aims to improve patient outcomes and quality of life through its innovative medicines. This commitment is central to their mission and guides their business practices. AbbVie's medicines have made a significant impact on patient outcomes across various therapeutic areas. For example, their immunology drugs have helped manage chronic autoimmune diseases, improving patients' quality of life. AbbVie is committed to corporate responsibility, including patient assistance programs and community support. In 2024, AbbVie continued its efforts to provide access to medicines for patients in need.

To gain more insights into AbbVie's investors and their motivations, check out this informative resource: Exploring AbbVie Inc. (ABBV) Investor Profile: Who’s Buying and Why?

AbbVie Inc. (ABBV) Core Values of

While specific, officially declared core values of AbbVie as of my knowledge cutoff in April 2025 are not available, we can analyze AbbVie's mission and vision, alongside their actions and stated priorities, to infer key values that drive the organization. These inferred values emphasize their approach to innovation, patient care, and social responsibility.

Innovation and Discovery

AbbVie emphasizes a commitment to innovation in biopharmaceuticals. This commitment is evident in their substantial investment in research and development. For example, in 2024, AbbVie invested $7.749 billion in R&D, demonstrating a dedication to discovering and developing new medicines. This investment supports a pipeline of potential new treatments across various therapeutic areas. Approximately 16.3% of AbbVie's net revenue was allocated to R&D in 2024, reflecting the high priority placed on innovation.

Patient-Centric Approach

A core value is a focus on patients' needs, which is reflected in AbbVie's mission to discover and deliver innovative medicines that solve serious health issues. Examples of this patient-centric approach include:

• Developing therapies that address unmet medical needs.
• Providing patient support programs to improve access to medications and adherence to treatment plans.
• Engaging with patient advocacy groups to understand patient perspectives and incorporate them into decision-making.

Integrity and Ethics

Operating with high ethical standards is crucial for AbbVie, especially given the heavily regulated nature of the pharmaceutical industry. Demonstrations of this value include:

• Adhering to all applicable laws and regulations.
• Maintaining transparency in interactions with healthcare professionals, patients, and other stakeholders.
• Promoting ethical business practices throughout the organization.

Collaboration and Partnership

AbbVie recognizes the importance of working with external partners to advance its mission. This is demonstrated through:

• Strategic alliances with other pharmaceutical and biotechnology companies.
• Collaborations with academic institutions and research organizations.
• Partnerships with patient advocacy groups and community organizations.

Social Responsibility

AbbVie is committed to making a positive impact on society through various initiatives. This commitment is illustrated by:

• Philanthropic activities, such as supporting access to healthcare for underserved populations.
• Environmental sustainability efforts to reduce the company's environmental footprint.
• Employee volunteer programs that encourage employees to give back to their communities.

AbbVie's commitment to these inferred core values underpins its operations and strategic decisions, influencing how the company innovates, engages with stakeholders, and contributes to society. For further insights into AbbVie's financial performance and strategic health, consider reading Breaking Down AbbVie Inc. (ABBV) Financial Health: Key Insights for Investors.